AltRx vs 10Rx: Monthly vs Quarterly Tirzepatide Pricing Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

AltRx and 10Rx both offer compounded tirzepatide injection at substantially lower headline costs than PlexusDx, but the structures differ materially. AltRx advertises promotional rates ending September 5, 2026—$149 per month on a monthly plan or $432 upfront for a three-month prepaid tier ($144/month, our calculation)—with post-promotion pricing unverified. 10Rx operates on a quarterly-only model: $450 upfront every three months ($150/month, our calculation), a figure we observed through secondary corroboration because the primary pricing page suppresses numeric totals. Over 12 months, AltRx's three-month prepaid promotional tier totals $1,728 (our calculation); 10Rx totals $1,800 (our calculation); PlexusDx month-to-month totals $3,468 at $289/month (our calculation). AltRx provides a month-to-month option and multiple prepaid tiers; 10Rx requires a quarterly upfront commitment. One Trustpilot report from 2026 alleges an unexpected annual pre-bill on AltRx despite selecting month-to-month; AltRx advertises "cancel anytime." If the promotional window or the prepaid commitment model fits your timeline and you accept the evidence limitations, either competitor delivers a lower upfront cost. If you prioritize transparent month-to-month billing, verified pricing, and PlexusDx's 4.2-star Trustpilot record (76% five-star, 81% four-star or higher, captured September 4, 2026), the economics shift. We document every conflict, label every calculation, and show you the complete 12-month picture.

At-a-glance comparison: AltRx vs 10Rx vs PlexusDx tirzepatide injection

All prepaid per-month calculations are ours. AltRx promotional rates captured September 4, 2026; promotion ends September 5, 2026. 10Rx quarterly total is secondary-corroborated; primary page suppresses numeric figures. PlexusDx rates captured September 5, 2026.

Like-for-like quarterly comparison: AltRx vs 10Rx

Both providers offer compounded tirzepatide injection in three-month packages; the structures require normalization. AltRx's three-month prepaid promotional tier costs $432 upfront every quarter, which works out to $144 per month (our calculation); this promotional rate ends September 5, 2026, and post-promotion pricing is unverified. 10Rx charges $450 upfront every three months, which works out to $150 per month (our calculation). Over 12 months, renewing the quarterly package four times, AltRx totals $1,728 (our calculation, promotional); 10Rx totals $1,800 (our calculation). The $6 per-month promotional difference compounds to $72 annually. AltRx's promotional edge holds only through the September 5, 2026 deadline; after that date, pricing is unknown and readers should confirm at checkout. The $450 10Rx figure is secondary-corroborated—the primary pricing page confirms the quarterly flat-rate structure and all inclusions but does not display the numeric total, so we advise confirming the figure during intake.

Evidence conflicts: 10Rx numeric totals and AltRx cancellation policy

10Rx's primary pricing page (captured September 4, 2026) verifies the quarterly prepaid structure, same-price-across-strengths policy, and full service inclusions—medication, clinician evaluation, next-day shipping, and support—but suppresses the package price itself. The $299 semaglutide and $450 tirzepatide quarterly totals come from secondary corroboration and should be confirmed at checkout. AltRx advertises "cancel anytime" on its promotional page (captured September 4, 2026). One captured Trustpilot report from 2026 alleges a full annual pre-bill despite the user selecting month-to-month; we present this as an individual allegation, not an established pattern, and recommend confirming billing terms with AltRx support before committing.

AltRx promotional monthly vs 10Rx quarterly-only model

AltRx offers a promotional month-to-month option at $149 per month (ending September 5, 2026), a structure 10Rx does not match—10Rx requires a three-month upfront commitment every cycle. Over 12 months, AltRx's promotional monthly plan totals $1,788 (our calculation); the three-month prepaid promotional tier totals $1,728 (our calculation), a $60 annual saving achieved by prepaying in quarterly blocks. 10Rx's quarterly-only model totals $1,800 annually (our calculation). If you prefer the flexibility to cancel or adjust without forfeiting prepaid funds, AltRx's promotional monthly tier provides that runway through September 5, 2026, at a $12 annual premium over 10Rx ($1,788 vs $1,800, our calculation). After the promotional deadline, the monthly option's pricing is unverified, and the quarterly structures become the only documented like-for-like comparison.

Dose policy and included services

All three providers charge the same rate regardless of dose strength. AltRx and 10Rx both include medical oversight, compounded medication, and shipping in the quoted package price; 10Rx advertises next-day shipping. PlexusDx includes the online provider visit, prescription, compounded medication, and shipping in the $289 monthly rate. None of the programs charge a separate membership fee. Dose adjustments—common as patients titrate toward efficacy or manage side effects—do not trigger price increases under any of these structures, a meaningful advantage over providers that tier pricing by milligram strength.

The 12-month total-cost picture

Comparing tirzepatide injection over 12 months, assuming continuous treatment without interruption:

All figures are our calculation based on captured pricing (AltRx and PlexusDx primary-public, 10Rx mixed-primary-secondary). AltRx promotional rates end September 5, 2026; post-promotion pricing unverified. Effective per-month figures for prepaid plans divide the upfront cost across three months.

AltRx's promotional three-month prepaid tier delivers the lowest 12-month total at $1,728 (our calculation), $72 below 10Rx and $1,740 below PlexusDx (our calculation). That advantage expires September 5, 2026. 10Rx's $1,800 annual total (our calculation) is $1,668 below PlexusDx. Both competitors require upfront quarterly commitments; PlexusDx operates month-to-month with no prepayment. The economic trade-off is transparency and flexibility against upfront savings: if the promotional window or the prepaid model aligns with your timeline and risk tolerance, the competitors offer lower entry costs. If you prioritize billing clarity, verified pricing, and the ability to cancel without forfeiting prepaid funds, PlexusDx's $289 month-to-month structure carries a premium but eliminates the prepaid commitment and promotional-deadline uncertainty.

Service quality and review records

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). We did not capture verified review data for AltRx or 10Rx during this research cycle. One Trustpilot report from 2026 alleges an unexpected full-year pre-bill on AltRx despite the user selecting month-to-month; AltRx's promotional page advertises "cancel anytime." We present that allegation as an individual user report, not an established pattern. Readers considering either competitor should verify billing terms, refund policies, and cancellation procedures with the provider's support team before committing, especially when prepaying for quarterly blocks.

Choose AltRx if…

• You can commit before September 5, 2026 and accept that post-promotion pricing is unverified.
• You prefer multiple prepaid tiers (3-month, 6-month, 12-month) or want a promotional month-to-month option through the deadline.
• The quarterly prepaid rate of $432 upfront ($144/month calculation, our calculation, promotional) fits your budget and timeline.
• You accept the Trustpilot allegation of unexpected billing as an isolated report and are prepared to confirm cancellation terms directly with AltRx support.

Choose 10Rx if…

• You are comfortable with a quarterly-only model and can prepay $450 every three months.
• You accept that the $450 tirzepatide quarterly total is secondary-corroborated and agree to confirm the figure during intake.
• You value next-day shipping and same-price-across-strengths transparency.
• You do not require a month-to-month billing option and can commit to three-month cycles.

Where PlexusDx fits

PlexusDx tirzepatide injection is $289 per month, month-to-month, with no membership fee and the same price at every dose. Over 12 months that totals $3,468 (our calculation), substantially above both AltRx's promotional tiers and 10Rx's quarterly structure. The economic premium buys three things: transparent month-to-month billing with no prepaid commitment, verified primary-public pricing with no promotional deadlines, and a 4.2-star Trustpilot record (76% five-star, 81% four-star or higher, captured September 4, 2026). If you prioritize billing clarity, the ability to cancel or adjust without forfeiting prepaid funds, and a documented service record, PlexusDx's structure delivers that predictability. If your primary decision variable is minimizing the monthly out-of-pocket cost and you accept the prepaid commitment and promotional-deadline constraints, AltRx or 10Rx will save you $1,668 to $1,740 annually (our calculation). Neither choice is wrong; the optimal fit depends on whether you value upfront savings or long-term flexibility and transparency.

Methodology and freshness

We captured AltRx promotional pricing from the primary promotional page (https://www.altrx.com/glp1/offer-v9-fl) on September 4, 2026 at 13:49:55 UTC; all AltRx rates are promotional and end September 5, 2026. We captured 10Rx structure and inclusions from the primary pricing page (https://www.take10rx.com/pricing) on September 4, 2026 at 13:49:55 UTC; the $450 tirzepatide quarterly total is secondary-corroborated because the primary page suppresses numeric package prices. We captured PlexusDx month-to-month tirzepatide pricing on September 5, 2026 at 10:37:09 UTC from the live product page. We captured PlexusDx Trustpilot data on September 4, 2026. All 12-month totals and per-month calculations for prepaid plans are ours, derived by multiplying the per-cycle cost by the number of cycles per year (four for quarterly plans) and dividing annual totals by 12 where stated as effective monthly rates. We label every conflict (10Rx numeric total secondary-corroborated; AltRx "cancel anytime" vs Trustpilot prebilling allegation; AltRx promotional deadline and unverified post-promotion pricing) and recommend confirming figures and billing terms at checkout. This article was written September 5, 2026.

Frequently Asked Questions

Does AltRx's promotional tirzepatide pricing continue after September 5, 2026?

All captured AltRx tirzepatide rates—$149 monthly and $432 three-month prepaid—are promotional and end September 5, 2026. Post-promotion pricing is not documented in our research. Readers should confirm current rates directly with AltRx if evaluating the program after that date.

Why is the 10Rx tirzepatide price labeled secondary-corroborated?

10Rx's primary pricing page confirms the quarterly prepaid structure, same-price-across-strengths policy, and full service inclusions, but the page does not display the numeric package total. The $450 tirzepatide quarterly figure comes from secondary corroboration. We recommend confirming the total during intake or with 10Rx support.

Which provider offers the lowest 12-month tirzepatide cost?

AltRx's three-month prepaid promotional tier totals $1,728 over 12 months (our calculation), the lowest captured figure, but the rate ends September 5, 2026. 10Rx totals $1,800 annually (our calculation) on its standard quarterly structure. PlexusDx month-to-month totals $3,468 (our calculation). AltRx and 10Rx require upfront quarterly commitments; PlexusDx bills monthly with no prepayment.

Can I cancel AltRx or 10Rx mid-cycle and receive a refund?

AltRx advertises "cancel anytime," but one 2026 Trustpilot report alleges unexpected annual prebilling. 10Rx operates on a quarterly prepaid model. Refund and cancellation policies for prepaid cycles are not detailed in our captured evidence. Confirm terms with each provider's support team before committing, especially when prepaying for multi-month blocks.

Does PlexusDx offer a prepaid tirzepatide discount to match AltRx or 10Rx?

No. PlexusDx tirzepatide injection is $289 per month on a month-to-month basis, with no multi-month prepaid tiers. The structure prioritizes billing transparency and cancellation flexibility over upfront discounts. Readers seeking the lowest per-month rate will find better economics with AltRx's promotional tiers (through September 5, 2026) or 10Rx's quarterly structure.

Sources

• PlexusDx tirzepatide injection pricing – plexusdx.com/products/tirzepatide-injection, accessed September 5, 2026
• AltRx promotional pricing page – altrx.com/glp1/offer-v9-fl, accessed September 4, 2026
• 10Rx pricing page – take10rx.com/pricing, accessed September 4, 2026
• PlexusDx Trustpilot profile – trustpilot.com, accessed September 4, 2026
• Secondary corroboration for 10Rx quarterly totals – multiple checkout observations, accessed September 4, 2026
• Trustpilot AltRx user report alleging annual prebilling – trustpilot.com, accessed 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.